Joris Guyon

Associate Professor

Centre Hospitalier Universitaire Vaudois

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Joris Guyon is an Associate Professor at the Centre Hospitalier Universitaire de Bordeaux, France. His research focuses on glioblastoma, exploring areas such as metabolic vulnerability, tumorigenicity, and cell motility within this aggressive brain cancer. Recent publications include studies on psychoactive substances and innovative therapeutic approaches targeting glioblastoma's growth and invasion mechanisms.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

Eric DUPLUS

Assistant Professor

Sorbonne Université

FRANCE

View details

Heidi Espedal

University of Western Australia

AUSTRALIA

View details

Thomas Daubon

University of Bordeaux

FRANCE

View details

Tiffanie Chouleur

Inserm U1028

FRANCE

View details

Audrey Burban

FRANCE

View details

Jason Mears

Assistant Professor

Case Western Reserve University School of Medicine

UNITED STATES

View details

Frank Kruyt

Professor

University Medical Center Groningen

NETHERLANDS

View details

Christophe Antoniewski

Sorbonne Université

FRANCE

View details

aurelie bedel

MCU-PH, Associate professor and clinician

FRANCE

View details

Georges Herbein

Head, Professor

Center For Biomarker Research In Medicine

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joris Guyon

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Psychoactive cocktail consumption on Reunion Island: a case report

Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile

Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes

GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.

Histological analysis of invasive glioblastoma organoids embedded in a 3D collagen matrix

Letter to the Editor: The Cannabinoid Consumed Is Not Necessarily the One Expected: Recent Experience with Hexahydrocannabinol

TGF-β promotes microtube formation in glioblastoma through Thrombospondin 1

Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase.

Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis

A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case

An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid

Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development

Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or Aneurysms.

Collaborators (10)

Eric DUPLUS

Heidi Espedal

Thomas Daubon

Tiffanie Chouleur

Audrey Burban

Jason Mears

Frank Kruyt

Christophe Antoniewski

aurelie bedel

Georges Herbein

Make your next move.